CyclohexanolsThiophenesAntidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agentsp-ChloroamphetamineDothiepinFluoxetineParoxetineDepressive Disorder, MajorAmitriptylineCyclohexanecarboxylic AcidsCitalopramClomipramineNorepinephrine Plasma Membrane Transport ProteinsHot FlashesSneezingAminesAntidepressive Agents, TricyclicSerotonin SyndromeDiabetic NeuropathiesDrug OverdoseNociceptive PainSertralineDesipramineDelayed-Action PreparationsNordefrinHidradenitis SuppurativaFibromyalgiaDouble-Blind MethodAnalgesicsSerotonin Plasma Membrane Transport ProteinsBiogenic MonoaminesSerotonin AgentsTreatment OutcomeDoxepinUrinary Incontinence, StressNeurotransmitter Uptake InhibitorsTablets, Enteric-CoatedSerotoninCyclopropanesDepressive Disorder1-NaphthylamineNormetanephrinePhentermineDrug InteractionsTyramineFemoral NeuropathyNorepinephrineRandomized Controlled Trials as Topicgamma-Aminobutyric AcidPainPlacebosPain MeasurementDepressionAdrenergic alpha-2 Receptor AntagonistsMethiothepinDose-Response Relationship, DrugPsychiatric Status Rating ScalesUrethraPhenylpropanolamineFluvoxamineIdazoxanMandelic AcidsDrug Therapy, CombinationCross-Over StudiesBupropionPoison Control CentersRats, Sprague-DawleyDrug CostsNeuralgiaRhabdomyolysisMethyltyrosinesForensic ToxicologyDepressive Disorder, Treatment-ResistantSuicideTramadolCytochrome P-450 CYP2D6Anxiety DisordersPlacebo EffectSalivationDrug Administration ScheduleNAV1.7 Voltage-Gated Sodium ChannelSymportersPentylenetetrazoleMianserinMethoxyhydroxyphenylglycol3,4-MethylenedioxyamphetamineIontophoresisReceptors, Serotonin, 5-HT4Chronic PainImmobilizationNootropic AgentsCresolsAnti-Anxiety AgentsMethoxamineAdverse Drug Reaction Reporting SystemsSwimmingCognitive Therapy